Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCidara Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | -$3.54 | -$3.54 | -$3.54 |
| Q2 2025 | 1 | -$2.72 | -$2.72 | -$2.72 |
| Q3 2025 | 1 | -$2.42 | -$2.42 | -$2.42 |
| Q4 2025 | 1 | -$2.08 | -$2.08 | -$2.08 |
Cidara Therapeutics, Inc. Earnings Date And Information
Cidara Therapeutics, Inc. last posted its earnings results on Thursday, March 6th, 2025. The company reported $-5.38 earnings per share for the quarter, missing analysts' consensus estimates of $-5.28 by $0.1. The company had revenue of 0 for the quarter and had revenue of 1.28 M for the year. Cidara Therapeutics, Inc. has generated $-27 earnings per share over the last year ($-26.82 diluted earnings per share) and currently has a price-to-earnings ratio of -0.88. Cidara Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 11th, 2025 based on prior year's report dates.
Cidara Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/06/2025 | Q4 2024 | -$5.28 | -$8.12 | -2.84 | $240,000 | $0 |
| 11/07/2024 | Q3 2024 | -$5.22 | -$2.38 | 2.84 | $433,333 | $0 |
| 08/13/2024 | Q2 2024 | -$3.94 | -$19.59 | -15.65 | $1.30 M | $302,000 |
| 05/15/2024 | Q1 2024 | N/A | -$2.28 | N/A | N/A | $8.46 M |
| 04/22/2024 | Q4 2023 | -$0.20 | -$1.25 | -1.05 | $13.95 M | $17.58 M |
| 11/02/2023 | Q3 2023 | -$2.80 | -$1.81 | 0.99 | $8.14 M | $12.72 M |
| 08/03/2023 | Q2 2023 | -$1.60 | -$2.80 | -1.2 | $11.55 M | $7.61 M |
| 05/11/2023 | Q1 2023 | $1.20 | $0.63 | -0.57 | N/A | $25.99 M |
| 03/23/2023 | Q4 2022 | -$0.20 | -$3.72 | -3.52 | N/A | $10.22 M |
| 11/03/2022 | Q3 2022 | $6.00 | $3.39 | -2.61 | $28.35 M | $40.74 M |
| 08/09/2022 | Q2 2022 | -$5.60 | -$4.98 | 0.62 | $6.21 M | $6.22 M |
| 05/11/2022 | Q1 2022 | -$5.20 | -$5.41 | -0.21 | N/A | $7.11 M |
| 03/07/2022 | Q4 2021 | -$6.60 | -$5.22 | 1.38 | N/A | $7.23 M |
| 11/10/2021 | Q3 2021 | -$7.40 | -$7.40 | 0 | $2.94 M | $7.08 M |
| 08/12/2021 | Q2 2021 | -$5.40 | $3.62 | 9.02 | $12.13 M | $32.86 M |
| 05/13/2021 | Q1 2021 | -$3.40 | -$8.72 | -5.32 | N/A | $2.41 M |
| 02/25/2021 | Q4 2020 | -$2.80 | -$9.80 | -7 | N/A | $3.73 M |
| 11/05/2020 | Q3 2020 | -$9.60 | -$8.16 | 1.44 | $4.89 M | $2.42 M |
| 08/13/2020 | Q2 2020 | -$4.80 | -$9.00 | -4.2 | $5.29 M | $3.39 M |
| 05/13/2020 | Q1 2020 | -$6.80 | -$7.68 | -0.88 | N/A | $2.53 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cidara Therapeutics, Inc. Earnings: FAQ's
Cidara Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 11th, 2025 based offlast year's report dates.
The conference call for Cidara Therapeutics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Cidara Therapeutics, Inc.'s latest earnings report can be read online.
Cidara Therapeutics, Inc. (:CDTX) has a recorded annual revenue of $1.28 M.
Cidara Therapeutics, Inc. (:CDTX) has a recorded net income of $-169,827,000.Cidara Therapeutics, Inc. has generated $-26.82 earnings per share over the last four quarters.
Cidara Therapeutics, Inc. (:CDTX) has a price-to-earnings ratio of -0.88 and price/earnings-to-growth ratio is 0.03.